Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2016, Article ID 5190846, 8 pages
http://dx.doi.org/10.1155/2016/5190846
Clinical Study

Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial

1Department of Clinical Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, P.O. Box 14155-6117, Tehran, Iran
2Department of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Health Information Management, Mazandaran University of Medical Sciences, Sari, Iran
4Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Received 23 December 2015; Revised 30 April 2016; Accepted 10 May 2016

Academic Editor: Phillip B. Hylemon

Copyright © 2016 Sadegh Jafarnejad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. This trial aims to examine the effects of a Probiotic Mixture (VSL#3) on glycemic status and inflammatory markers, in women with GDM. Materials and Methods. Over a period of 8 weeks, 82 women with gestational diabetes were randomly assigned to either an intervention group () which were given VSL#3 capsule or to a control group which were given placebo capsule (). Fasting plasma glucose, homeostatic model assessment of insulin resistance, glycosylated hemoglobin, high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin-6, Interferon gamma, and interleukin-10 were measured before and after the intervention. Results. After 8 wk of supplementation FPG, HbA1c, HOMA-IR, and insulin levels remained unchanged in the probiotic and placebo groups. The comparison between the two groups showed no significant differences with FPG and HbA1c, but there were significant differences in insulin levels and HOMA-IR (; , resp.). Unlike the levels of IFN-g (), there was a significant decrease in levels of IL-6 (), TNF-α (), and hs-CRP (). No significant increase was observed in IL-10 () in the intervention group as compared with the control group. Conclusions. In women with GDM, supplementation with probiotics (VSL#3) may help to modulate some inflammatory markers and may have benefits on glycemic control.